Tuesday, September 09, 2014 8:57:39 AM
Posted by Nolan Pearson on Sep 9th, 2014
Click For wkrb13.com Link
Research analysts at Citigroup Inc. started coverage on shares of Synchrony Financial (NYSE:SYF) in a report released on Tuesday. The firm set a “buy” rating and a $30.00 price target on the stock.
Citigroup Inc.’s price target points to a potential upside of 20.77% from the company’s current price.
SYF has been the subject of a number of other recent research reports. Analysts at Morgan Stanley initiated coverage on shares of Synchrony Financial in a research note on Tuesday. They set an “overweight” rating and a $30.00 price target on the stock. Separately, analysts at Goldman Sachs initiated coverage on shares of Synchrony Financial in a research note on Tuesday. They set a “buy” rating and a $30.00 price target on the stock. Finally, analysts at Credit Suisse initiated coverage on shares of Synchrony Financial in a research note on Tuesday. They set an “outperform” rating and a $30.00 price target on the stock. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $28.27.
Shares of Synchrony Financial (NYSE:SYF) opened at 24.84 on Tuesday. Synchrony Financial has a 1-year low of $22.60 and a 1-year high of $26.02. The stock’s 50-day moving average is $24.24 and its 200-day moving average is $24.24. The company has a market cap of $20.624 billion and a price-to-earnings ratio of 10.91.
Synchrony Financial (NYSE:SYF) is a consumer financial services companies in the United States.
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of solutions.
Recent SYF News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 08:33:49 PM
- Synchrony Extends Partnership with Affordable Care Offering CareCredit to Patients • PR Newswire (US) • 05/02/2024 01:00:00 PM
- Synchrony and ServiceTitan Join Forces to Streamline Home Improvement Financing • PR Newswire (US) • 04/30/2024 01:00:00 PM
- Synchrony Reports First Quarter 2024 Results; Company also Announces Quarterly Stock Dividends and Approval of an Incremental $1.0 Billion Share Repurchase Program • PR Newswire (US) • 04/24/2024 10:13:00 AM
- Synchrony Expands Dental Payment Offerings with Adit Practice Management Software Partnership • PR Newswire (US) • 04/18/2024 01:00:00 PM
- Synchrony Partners with BRP to Provide Retail Financing Options in the United States • PR Newswire (US) • 04/08/2024 01:00:00 PM
- SYNCHRONY RECOGNIZED FOR ITS PEOPLE-CENTRIC CULTURE WITH NEW COMPANY RANKING • PR Newswire (US) • 04/04/2024 12:38:00 PM
- Synchrony to Announce First Quarter 2024 Financial Results on April 24, 2024 • PR Newswire (US) • 03/26/2024 12:00:00 PM
- Skipify and Synchrony Enter into Strategic Partnership to Simplify and Enhance Online Checkout • PR Newswire (US) • 03/13/2024 01:00:00 PM
- IPH ENTERS STRATEGIC PARTNERSHIP WITH SYNCHRONY AND COMPLETES ACQUISITION OF PETS BEST • PR Newswire (US) • 03/06/2024 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:28:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:28:41 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 10:24:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:40:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:00:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 08:45:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 06:52:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 05:41:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:30:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM